Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenues $ 36,959 $ 31,204 $ 102,420 $ 95,821
Cost of goods sold 6,176 5,239 18,006 17,503
Gross profit 30,783 25,965 84,414 78,318
Costs and expenses:        
Sales and marketing 19,792 18,370 60,349 55,594
Research and development 7,050 6,404 20,347 17,875
General and administrative 8,796 7,880 27,817 24,912
Total costs and expenses 35,638 32,654 108,513 98,381
Loss from operations (4,855) (6,689) (24,099) (20,063)
Other (expense) income:        
Investment income 186 17 172 80
Interest expense (61) (417) (664) (1,427)
Change in fair value of derivatives 469 (46) 1,155 (152)
Other expense (57) (6) (97) (137)
Total other expense, net 537 (452) 566 (1,636)
Net loss $ (4,318) $ (7,141) $ (23,533) $ (21,699)
Weighted average common shares outstanding - basic (in shares) 42,220,519 41,467,596 42,008,013 41,087,568
Weighted average common shares outstanding - diluted (in shares) 42,220,519 41,467,596 42,008,013 41,087,568
Loss per common share - basic (in dollars per share) $ (0.10) $ (0.17) $ (0.56) $ (0.53)
Loss per common share - diluted (in dollars per share) $ (0.10) $ (0.17) $ (0.56) $ (0.53)